Drug - Fenofibrate
August 2009
Therapeutic area - Cardiovascular
Preferred | Nonpreferred - PA required (all are fenofibrate) |
Tricor 48 mg, 145 mg
Trilipix 45 mg, 135 mg |
Antara
Fenofibrate (tablets and capsules) Fenoglide Fibricor (35mg, 105mg) Lofibra Lipofen Triglide |
Patient does not receive adequate triglyceride lowering from the preferred fenofibrates or has allergy or intolerance to a preferred fenofibrate.
DHS is not proposing that patients be switched from a branded fenofibrate to gemfibrozil.
There is no evidence to support superior efficacy of any one brand in this class.
Each of these brands has the same FDA indication:
Each of these brands is dosed once daily.
See Grandfathering Criteria – which indicate patient specific criteria that would exclude a patient from switching to a preferred drug.
MHCP Provider Call Center 651-431-2700 or 800-366-5411